Protagenic Therapeutics, Inc.

( )
PTIX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Technology Services » Internet Software Or Services
FBFacebook, Inc. 0.55%342.450.7%$5024.53m
GOOGAlphabet, Inc. 0.57%2543.650.5%$3109.23m
GOOGLAlphabet, Inc. 0.45%2453.490.5%$2949.91m
SNAPSnap, Inc. 1.69%67.502.4%$984.25m
DKNGDraftKings, Inc. 0.87%50.970.0%$843.95m
FUTUFutu Holdings Ltd. 1.12%171.550.0%$814.76m
TWTRTwitter, Inc. 0.42%66.748.8%$813.13m
SESea Ltd. (Singapore) 0.74%283.003.3%$767.70m
BIDUBaidu, Inc. 0.96%190.992.3%$765.00m
UPSTUpstart Holdings, Inc. 1.45%126.960.0%$744.96m
PINSPinterest, Inc. 0.71%75.300.0%$725.17m
DASHDoorDash, Inc. -0.60%173.000.0%$713.68m
MELIMercadoLibre, Inc. 0.93%1547.003.6%$648.06m
MSTRMicroStrategy, Inc. 1.63%562.003.0%$521.83m
BILIBilibili, Inc. 0.97%115.470.0%$450.96m

Company Profile

Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.